Ephemeral Diabetes After COVID-19 Vaccination.

JCEM case reports Pub Date : 2024-12-13 eCollection Date: 2025-01-01 DOI:10.1210/jcemcr/luae228
Sarah-Ålivia Mänd, Åke Sjöholm
{"title":"Ephemeral Diabetes After COVID-19 Vaccination.","authors":"Sarah-Ålivia Mänd, Åke Sjöholm","doi":"10.1210/jcemcr/luae228","DOIUrl":null,"url":null,"abstract":"<p><p>We report a case of new-onset, nonautoimmune, nonketotic, and noninsulinopenic type 2-like diabetes in a previously normoglycemic middle-aged man debuting after vaccination against COVID-19. This was not a mild or short-lived glucose intolerance, but severe and long-standing hyperglycemia with a high glycated hemoglobin level. However, the course of the diabetes was highly atypical and surprising in that it spontaneously disappeared after a few months and did not recur despite the patient being off all antidiabetic drugs for several months and without any changes in body weight or lifestyle. The mechanisms by which severe diabetes unfolded and later remitted in this patient remain elusive. Nonetheless, and notwithstanding whether or not there was a cause-and-effect relation between the vaccinations and his diabetes, the highly atypical course of spontaneously remitting nonautoimmune diabetes lends itself to mechanistic efforts aimed at understanding the biology and pathophysiology of insulin-producing β cells in health and disease. This case report should not be construed as vaccine skepticism or deter anyone, especially with diabetes/obesity, from vaccination against COVID-19. However, it calls for increased vigilance among health care providers for unusual and unexpected metabolic effects of COVID-19 and its vaccines.</p>","PeriodicalId":73540,"journal":{"name":"JCEM case reports","volume":"3 1","pages":"luae228"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11644471/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JCEM case reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1210/jcemcr/luae228","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

We report a case of new-onset, nonautoimmune, nonketotic, and noninsulinopenic type 2-like diabetes in a previously normoglycemic middle-aged man debuting after vaccination against COVID-19. This was not a mild or short-lived glucose intolerance, but severe and long-standing hyperglycemia with a high glycated hemoglobin level. However, the course of the diabetes was highly atypical and surprising in that it spontaneously disappeared after a few months and did not recur despite the patient being off all antidiabetic drugs for several months and without any changes in body weight or lifestyle. The mechanisms by which severe diabetes unfolded and later remitted in this patient remain elusive. Nonetheless, and notwithstanding whether or not there was a cause-and-effect relation between the vaccinations and his diabetes, the highly atypical course of spontaneously remitting nonautoimmune diabetes lends itself to mechanistic efforts aimed at understanding the biology and pathophysiology of insulin-producing β cells in health and disease. This case report should not be construed as vaccine skepticism or deter anyone, especially with diabetes/obesity, from vaccination against COVID-19. However, it calls for increased vigilance among health care providers for unusual and unexpected metabolic effects of COVID-19 and its vaccines.

接种 COVID-19 疫苗后的短暂糖尿病
我们报告了一例接种 COVID-19 疫苗后新发的非自身免疫性、非酮症和非胰岛素减少性 2 型糖尿病病例,患者是一名血糖正常的中年男子。这不是轻微或短暂的葡萄糖不耐受,而是严重和长期的高血糖,糖化血红蛋白水平很高。然而,这种糖尿病的病程却非常不典型,而且令人惊讶的是,尽管患者已停用所有抗糖尿病药物数月,体重或生活方式也没有任何改变,但糖尿病却在数月后自动消失,而且没有复发。该患者严重糖尿病的发生和缓解机制至今仍难以捉摸。尽管如此,且不论疫苗接种与糖尿病之间是否存在因果关系,自发缓解的非自身免疫性糖尿病的高度非典型病程有助于人们从机理上理解健康和疾病中分泌胰岛素的β细胞的生物学和病理生理学。本病例报告不应被理解为疫苗怀疑论或阻止任何人(尤其是糖尿病/肥胖症患者)接种 COVID-19 疫苗。但是,它呼吁医疗保健提供者提高警惕,警惕 COVID-19 及其疫苗对代谢产生的异常和意外影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信